To include your compound in the COVID-19 Resource Center, submit it here.

Nichi-Iko acquiring Sagent

Nichi-Iko Pharmaceutical Co. Ltd. (Tokyo:4541) said it will acquire

Read the full 95 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE